Development And Validation Of A Surgical-Pathologic Staging And Scoring System For Cervical Cancer
Shuang Li,Xiong Li,Yuan Zhang,Hang Zhou,Fangxu Tang,Yao Jia,Ting Hu,Haiying Sun,Ru Yang,Yile Chen,Xiaodong Cheng,Weiguo Lv,Li Wu,Jin Zhou,Shaoshuai Wang,Kecheng Huang,Lin Wang,Yuan Yao,Qifeng Yang,Xingsheng Yang,Qinghua Zhang,Xiaobing Han,Zhongqiu Lin,Hui Xing,Pengpeng Qu,Hongbing Cai,Xiaojie Song,Xiaoyu Tian,Jian Shen,Ling Xi,Kezhen Li,Dongrui Deng,Hui Wang,Changyu Wang,Mingfu Wu,Tao Zhu,Gang Chen,Qinglei Gao,Shixuan Wang,Junbo Hu,Beihua Kong,Xing Xie,Ding Ma
DOI: https://doi.org/10.18632/oncotarget.8245
2016-01-01
Oncotarget
Abstract:Background: Most cervical cancer patients worldwide receive surgical treatments, and yet the current International Federation of Gynecology and Obstetrics (FIGO) staging system do not consider surgical-pathologic data. We propose a more comprehensive and prognostically valuable surgical-pathologic staging and scoring system (SPSs).Methods: Records from 4,220 eligible cervical cancer cases (Cohort 1) were screened for surgical-pathologic risk factors. We constructed a surgical-pathologic staging and SPSs, which was subsequently validated in a prospective study of 1,104 cervical cancer patients (Cohort 2).Results: In Cohort 1, seven independent risk factors were associated with patient outcome: lymph node metastasis (LNM), parametrial involvement, histological type, grade, tumor size, stromal invasion, and lymph-vascular space invasion (LVSI). The FIGO staging system was revised and expanded into a surgical-pathologic staging system by including additional criteria of LNM, stromal invasion, and LVSI. LNM was subdivided into three categories based on number and location of metastases. Inclusion of all seven prognostic risk factors improves practical applicability. Patients were stratified into three SPSs risk categories: zero-, low-, and high-score with scores of 0, 1 to 3, and >= 4 (P=1.08E-45; P=6.15E-55). In Cohort 2, 5-year overall survival (OS) and disease-free survival (DFS) outcomes decreased with increased SPSs scores (P=9.04E-15; P=3.23E-16), validating the approach. Surgical-pathologic staging and SPSs show greater homogeneity and discriminatory utility than FIGO staging.Conclusions: Surgical-pathologic staging and SPSs improve characterization of tumor severity and disease invasion, which may more accurately predict outcome and guide postoperative therapy.